Holen Sie sich die Stockscreener-App
7.17
1.41%
0.10
Handel nachbörslich:
7.15
-0.02
-0.28%
Advisorshares Pure Us Cannabis Etf Aktie (MSOS) Neueste Nachrichten
Cabot Cannabis Investor Issue: September 25, 2024 - Cabot Wealth Network
(MSOS) Investment Analysis - Stock Traders Daily
Cannabis Investor Sentiment Softens As Institutional Confidence Wanes, Survey Shows - Benzinga
What investors need to know about active bond ETFs as Fed prepares rate cuts - MarketWatch
The Economic Benefits of Legalizing Marijuana - Investopedia
Will The DEA Complete Cannabis Rescheduling? Hear From Experts The Day After Harris-Trump Debate - Benzinga
5 ETFs That Led the Rebound on Monday - Yahoo Finance
Cannabis stocks rally as Trump backs rescheduling, Florida legalization - Proactive Investors USA
Looking for the Next Big Growth Opportunity? It Might Not Be in Artificial Intelligence. - The Motley Fool
Cannabis Legalization Is Very Popular. Here’s Why the Stocks Aren’t. - Barron's
(MSOS) Trading Signals - Stock Traders Daily
Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit? - Benzinga
Cannabis stocks rally as analyst hails pot as an ‘increasingly bipartisan’ issue - MarketWatch
6 Best-Performing Marijuana ETFs for September 2024 - NerdWallet
This small-cap ETF drew investors after Fed nod to rate cuts. Can it keep it up? - MarketWatch
Cannabis Stocks Tumble on News of DEA’s Rescheduling Shakeup - mg Magazine
Cheaper Than A Big Mac: Weed Penny Stocks Emerge As Winners Amidst Market Downturn - Benzinga
Small caps and the U.S. election: How investors can win in the home stretch - Kursiv Media
AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS) Shares Gap Down to $7.04 - Defense World
Here’s why Tilray Brands, Canopy Growth, Curaleaf stocks have crashed - MSN
Here’s why Tilray Brands, Canopy Growth, Curaleaf stocks have crashed - Invezz
Pot stocks fall as US DEA pushes cannabis reclassification hearing to December - Reuters
Cabot Cannabis Investor Issue: August 28, 2024 - Cabot Wealth Network
Congressman Blumenauer Slams DEA For Postponing Marijuana Rescheduling, Places Hope In Soon-To-Be President Harris - Benzinga
Rescheduling Delay Sends Cannabis Stocks Into Tailspin - Business of Cannabis -
Stock Traders Buy High Volume of Call Options on AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS) - Defense World
Pot stocks fall as US DEA pushes cannabis reclassification hearing to December - ETHealthWorld
Cannabis stocks slide after DEA decides to push back reclassification hearing - Mugglehead
Pot stocks fall as US DEA pushes cannabis reclassification hearing to December - WKZO
Cannabis stocks tumble as rescheduling hopes get slapped - Crain's Cleveland Business
Cannabis stocks tumble as rescheduling hopes get slapped - Green Market Report
Pot stocks fall as US DEA pushes cannabis reclassification hearing to December - Yahoo Canada Finance
Pot stocks fall as US DEA pushes cannabis reclassification hearing to December - WHBL
Cannabis Stocks Plummet By Up To 16% On DEA Rescheduling Delay: Could This Be The Buying Opportunity Of 2024? - AOL
Cannabis stocks slide as DEA delays marijuana rescheduling until after the US election - Proactive Investors Australia
Cannabis Stocks Plummet By Up To 16% On DEA Rescheduling Delay: Could This Be The Buying Opportunity Of 2024? - Benzinga
Cannabis stocks on watch as DEA sets hearing on marijuana rescheduling - Seeking Alpha
Cannabis stocks slide as DEA delays marijuana rescheduling until after the US election - Proactive Investors USA
New SEC Filings Reveal Risks In Cannabis ETFs Following Recent Volatility — But There's Still Room For Optimism (CORRECTED)4Front Ventures (OTC:FFNTF), Green Thumb Industries (OTC:GTBIF) - Benzinga
AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS) Shares Gap Up to $7.58 - Defense World
0.36%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):